Latest Healthcare News

Page 180 of 182
SomnoMed reports a robust 19.8% revenue increase in Q2 FY25 and updates its full-year guidance, reflecting strong demand and operational improvements amid ongoing production enhancements.
Ada Torres
Ada Torres
24 Jan 2025
Pacific Smiles Group reports robust patient fee growth of over 9% year-on-year and reaffirms FY25 guidance, while announcing a CFO change as Genesis Capital solidifies its majority stake.
Ada Torres
Ada Torres
24 Jan 2025
InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.
Ada Torres
Ada Torres
23 Jan 2025
InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.
Ada Torres
Ada Torres
23 Jan 2025
Cardiex Limited has commenced U.S. deliveries of its CONNEQT Pulse arterial health monitor alongside the launch of its companion CONNEQT App, marking a pivotal expansion into the American digital health market.
Ada Torres
Ada Torres
23 Jan 2025
Universal Biosensors has secured a Vendor Master Purchase Agreement with Chewy and launched its Petrackr veterinary glucose monitoring system on Amazon, positioning itself for significant growth in North America's online pet care market.
Ada Torres
Ada Torres
23 Jan 2025
Talius Group reports a robust December quarter with $4.4 million revenue, positive operating cash flow, and a strategic $2.5 million capital raise, positioning the company for strong growth in 2025 amid evolving aged care legislation.
Ada Torres
Ada Torres
23 Jan 2025
Hydrix Limited has extended its contract with Paul Hartmann AG, adding $2.8 million in revenue and reinforcing its international growth strategy.
Ada Torres
Ada Torres
23 Jan 2025
Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.
Ada Torres
Ada Torres
23 Jan 2025
Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.
Ada Torres
Ada Torres
23 Jan 2025
Nanosonics delivers a robust H1 FY25 trading update, reporting an 18% rise in revenue to $93.6 million and a profit before tax of $10.9 million, signaling strong momentum in its infection prevention business.
Ada Torres
Ada Torres
23 Jan 2025
Cyclopharm has inked a pivotal three-year agreement with HCA Healthcare, enabling deployment of its Technegas® lung imaging technology across up to 169 US nuclear medicine departments. This deal marks a major step in expanding Technegas®’ footprint in the American healthcare market.
Ada Torres
Ada Torres
23 Jan 2025